相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials
Luciano J. Costa et al.
LEUKEMIA (2021)
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma
Noemi Puig et al.
CANCERS (2021)
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma
Bruno Paiva et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma
Sandra Maria Dold et al.
HAEMATOLOGICA (2020)
Brief communication: Distribution of bone marrow cell subsets and hemodilution in patients with acute leukemia
Georgina Gener et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
Bone marrow particle enrichment analysis for the laboratory diagnosis of multiple myeloma: A case study
Congming Zhang et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)
Matthew Ho et al.
LEUKEMIA (2020)
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
Jens Hillengass et al.
LANCET ONCOLOGY (2019)
Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives
Alessandra Romano et al.
FRONTIERS IN ONCOLOGY (2019)
Toward personalized treatment in multiple myeloma based on molecular characteristics
Charlotte Pawlyn et al.
BLOOD (2019)
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis
Manuela Gambella et al.
CANCER (2019)
Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma
L. Rasche et al.
LEUKEMIA (2019)
Accurate quantification of fourteen normal bone marrow cell subsets in infants to the elderly by flow cytometry
Julie Pont et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2018)
Flow Cytometric Analysis of Mechanically Disaggregated Bone Marrow Trephine Biopsies
M. Wheeler et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2018)
Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials
Juan-Jose Lahuerta et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A simple flow-cytometry method to evaluate peripheral blood contamination of bone marrow aspirates
Jose Antonio Delgado et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
J. Flores-Montero et al.
LEUKEMIA (2017)
Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma A Meta-analysis
Nikhil C. Munshi et al.
JAMA ONCOLOGY (2017)
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications
Kenneth C. Anderson et al.
CLINICAL CANCER RESEARCH (2017)
Consensus Guidelines on Plasma Cell Myeloma Minimal Residual Disease Analysis and Reporting
Maria Arroz et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2016)
Consensus Guidelines for Myeloma Minimal Residual Disease Sample Staining and Data Acquisition
Maryalice Stetler-Stevenson et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2016)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar et al.
LANCET ONCOLOGY (2016)
Is This the Time to Introduce Minimal Residual Disease in Multiple Myeloma Clinical Practice?
Bruno Paiva et al.
CLINICAL CANCER RESEARCH (2015)
ICSH guidelines for the standardization of bone marrow immunohistochemistry
E. E. Torlakovic et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2015)
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
Joaquin Martinez-Lopez et al.
BLOOD (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry
N. Puig et al.
LEUKEMIA (2014)
Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013
Joseph R. Mikhael et al.
MAYO CLINIC PROCEEDINGS (2013)
High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma
Bruno Paiva et al.
BLOOD (2012)
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
T. Kalina et al.
LEUKEMIA (2012)
Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma
B. Paiva et al.
LEUKEMIA (2011)
分享论文
